15 August 2018
Visiongain’s new report Global Women’s Healthcare Market Forecast 2017-2027: Postmenopausal Osteoporosis, Hormonal Contraceptives, Menopause, Infertility, Endometriosis, Polycystic Ovary Syndrome indicates that the global women’s healthcare market will see $37.5bn in spending in 2021.
The revenue of the women’s healthcare market in 2016 is estimated at $31.1bn and is expected to grow at a CAGR of 3.8% in the first half of the forecast period. Among various segments in the Women’s Healthcare market, the Postmenopausal Osteoporosis segment dominated the Global Women's Healthcare market with a share of 36.99% in 2016.
The lead analyst of the report said: “ The Global Women's Healthcare market is driven by several factors, of which the increasing aging female population is one of the major drivers. With the increase in age and onset of menopause, women's risk factors for various conditions are high. The expected launch of pipeline molecules is another driver in this market.
The 154-page report contains 95 charts that add visual analysis in order to explain the developing trends within the Global Women’s Healthcare Market.
Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the global women’s healthcare market and its leading submarkets: Postmenopausal Osteoporosis, Hormonal Contraceptives, Menopause, Infertility, Endometriosis, Polycystic Ovary Syndrome
The 154-page report offers market forecasts for the leading regional and national markets: US and Latin America, Japan, the UK, Germany, France, Spain, Italy, Rest of Europe, Rest of the World.
This report provides discussion on pipeline products in various stages of clinical trials and regulatory approval. This report also discusses the drivers, challenges and trends that affect the global women’s healthcare market
Moreover, our work discusses the leading companies in the women’s healthcare market. Our study also discusses the SWOT Analysis of the submarkets and leading companies.
The report Global Women’s Healthcare Market Forecast 2017-2027: Postmenopausal Osteoporosis, Hormonal Contraceptives, Menopause, Infertility, Endometriosis, Polycystic Ovary Syndrome report will be of value to anyone who wants to better understand the global women’s healthcare market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the global women’s healthcare market.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global Bioreactors market was estimated to be valued at US$9,977.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.
29 September 2023
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
27 September 2023
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
25 September 2023
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.